Metalloradical Complexes of Mn and Cr
Chart 1
containing cofactor in the RNR of the bacterium Chlamydia
trachomatis, is expected to fuel interest in the generation
and function of redox-active residues in tandem with Mn
centers.5
We have previously shown8 that compound [(L1)Fe(II)-
THF]-, where L1 is the trisamido-amine ligand [(4-t-Bu-
C6H4)NC6H4]3N3- (Chart 1), can be oxidized by dioxygen
in THF to afford [(L1re-1)Fe-O-Fe(L1re-1)] as a minor product.
The ligand in this diferric µ-oxo species has undergone one-
electron oxidative rearrangement, while the oxidation equiva-
lent is retained as a π radical. In the present study we
demonstrate that the corresponding Mn(II) complex can
generate a rare Mn(III)(µ-O)2Mn(III) core-containing ana-
logue, as the major product of its reaction with dioxygen.
Moreover, the [(L1re-1)Mn(III)] oxidation level can be
replicated in a mononuclear [(L1re-1)Cr(III)]-containing
compound, using CrCl3 as oxidant.
using Schlenk techniques on an inert gas/vacuum manifold or in a
drybox (O2, H2O < 1 ppm). Anhydrous diethyl ether, methylene
chloride, acetonitrile, tetrahydrofuran, hexane, pentane, and toluene
were purchased from Sigma-Aldrich. Acetone was distilled over
drierite. Solvents were degassed by three freeze-pump-thaw
cycles. Unless otherwise noted, all other reagents were purchased
at the highest purity available. Potassium hydride was provided as
dispersion in mineral oil and was thoroughly washed prior to use
with copious amounts of tetrahydrofuran followed by hexane. The
synthesis of the ligand L1H3 has been previously described.9 1H
NMR and 13C NMR spectra were recorded on Varian XL-400,
Varian INOVA/UNITY 400 MHz, Varian 300 Unity Plus, and
Varian 600 MHz FT-HR-NMR spectrometers. FT-IR spectra were
obtained on Nicolet Nexus 470, 670, and Magna 750 FT-IR ESP
spectrometers and on a Bruker EQUINOX 55 spectrometer with a
single reflection accessory (DuraSamplIR II by SensIR Technolo-
gies) equipped with a diamond element. UV-vis spectra were
obtained on a Hewlett-Packard 8452A diode array spectrometer
and a Varian Cary 50 spectrophotometer. EI and CI mass spectra
were obtained on a Finnigan MAT-90 mass spectrometer. HRMS
(ESI) data were collected on an Applied Biosystems QStar Pulsar
instrument with a microspray ion source, located at the University
of Missouri-Columbia. Microanalyses were done by Quantitative
Technologies Inc., Whitehouse, NJ, Galbraith Laboratories, Inc.,
Knoxville, TN, and on an in-house Perkin-Elmer 2400 CHN
analyzer.
Dual mode X-band EPR spectra were recorded at the Institute
of Materials Science, NCSR “Demokritos”, on an extensively
upgraded former Bruker ER-200D spectrometer interfaced with a
personal computer running appropriate software in the LabView
programming environment. The spectrometer was equipped with
an Oxford ESR 900 cryostat, an Anritsu MF76A frequency counter,
and a Bruker 035 M NMR gaussmeter. The perpendicular mode
spectra were obtained with the 4102ST cavity, whereas the parallel
mode spectra were obtained with the dual mode cavity, 4116 DM.
Simulations of the spectra were performed with the software
SpinCount kindly provided to us by Prof. M. P. Hendrich,
Department of Chemistry, Carnegie Mellon University, Pittsburgh,
PA, USA. X-band EPR spectra were recorded on a Bruker
Instruments Model ESP 300 with an EMX upgrade, supported by
an APD Cryogenics Co. Cryostat HELI-TRAN model LTR-3,
located at the Chemistry Department of Dartmouth College, NH.
[(L1)Mn(II)-THF][K(THF)x] (1a) and [(L1)Mn(II)-THF]-
(Ph4P)·3THF (1b). Ligand L1H3 (0.343 g, 0.5 mmol) was dissolved
in degassed THF (15.0 mL), to which KH (0.060 g, 1.5 mmol)
was added. The mixture was stirred overnight until all KH was
dissolved. MnCl2 (0.0625 g, 0.5 mmol) was then added as solid to
the resulting yellow THF solution. This mixture was stirred for
another 10 h to give a pale yellow solution. This solution was
Experimental Section
General Considerations. All operations were performed under
anaerobic conditions under a pure dinitrogen or argon atmosphere
(3) (a) Dismukes, G. C. Chem. ReV. 1996, 96, 2909–2926. (b) Mukho-
padhyay, S.; Mandal, S. K.; Bhaduri, S.; Armstrong, W. H. Chem.
ReV. 2004, 104, 3981–4026. (c) Wu, A. J.; Penner-Hahn, J. E.;
Pecoraro, V. L. Chem. ReV. 2004, 104, 903–938. (d) Jedrzejas, M. J.;
Setlow, P. Chem. ReV. 2001, 101, 607–618. (e) Gold, M. H.; Youngs,
H. L.; Sollewijn, G.; Maarten, D. In Metal Ions in Biological Systems:
Manganese and Its Role in Biological Processes; Sigel, A., Sigel, H.,
Eds.; Marcel Dekker, Inc.: New York, Basel, 2000; Vol. 37, pp
559-586. (f) Ash, D. E.; Cox, J. D.; Christianson, D. W. In Metal
Ions in Biological Systems: Manganese and Its Role in Biological
Processes; Sigel, A., Sigel, H., Eds.; Marcel Dekker, Inc.: New York,
Basel, 2000; Vol. 37, pp 407-428. (g) Bogumil, R.; Kappl, R.;
Huttermann, J. In Metal Ions in Biological Systems: Manganese and
Its Role in Biological Processes; Sigel, A., Sigel, H., Eds.; Marcel
Dekker, Inc.: New York, Basel, 2000; Vol. 37, pp. 365-405. (h)
Rusnak, F. In Metal Ions in Biological Systems: Manganese and Its
Role in Biological Processes; Sigel, A., Sigel, H., Eds.; Marcel Dekker,
Inc.: New York, Basel, 2000; Vol. 37, pp 305-343. (i) Crowley, J. D.;
Traynor, D. A.; Weatherburn, D. C. In Metal Ions in Biological
Systems: Manganese and Its Role in Biological Processes; Sigel, A.,
Sigel, H., Eds.; Marcel Dekker, Inc.: New York, Basel, 2000; Vol.
37, pp 209-278. (j) Christianson, D. W.; Cox, J. D. Annu. ReV.
Biochem. 1999, 68, 33–57. (k) Weatherburn, D. C. In PerspectiVes
on Bioinorganic Chemistry1996, 3, 1-113.
(4) (a) Brautigan, D. L.; Kruszewski, A.; Wang, H. Biochem. Biophys.
Res. Commun. 2006, 347, 769–773. (b) Wang, H.; Kruszewski, A.;
Brautigan, D. L. Biochemistry 2005, 44, 8167–8175. (c) Kawanishi,
S.; Inoue, S.; Sano, S. J. Biol. Chem. 1986, 261, 5952–5958. (d) Shi,
X.; Dalal, N. S. Biochem. Biophys. Res. Commun. 1988, 156, 137–
142.
(5) Jiang, W.; Yun, D.; Saleh, L.; Barr, E. W.; Xing, G.; Hoffart, L. M.;
Maslak, M.-A.; Krebs, C.; Bollinger, J. M., Jr. Science 2007, 316,
1188–1191.
(6) (a) Goodson, P. A.; Glerup, J.; Hodgson, D. J.; Michelsen, K.;
Pedersen, E. Inorg. Chem. 1990, 29, 503–508. (b) Goodson, P. A.;
Glerup, J.; Hodgson, D. J.; Michelsen, K.; Weihe, H. Inorg. Chem.
1991, 30, 4909–4914. (c) Manchanda, R.; Brudvig, G. W.; de Gala,
S.; Crabtree, R. H. Inorg. Chem. 1994, 33, 5157–5160. (d) Jensen,
A. F.; Su, Z.; Hansen, N. K.; Larsen, F. K. Inorg. Chem. 1995, 34,
4244–4252. (e) Horner, O.; Charlot, M.-F.; Boussac, A.; Anxolabe´he´re-
Mallart, E.; Tchertanov, L.; Guilhem, J.; Girerd, J.-J. Eur. J. Inorg.
Chem. 1998, 721–727. (f) Hureau, C.; Blondin, G.; Cesario, M.; Un,
S. J. Am. Chem. Soc. 2003, 125, 11637–11645. (g) Chen, H.; Tagore,
R.; Das, S.; Incarvito, C.; Faller, J. W.; Crabtree, R. H; Brudvig, G. W.
Inorg. Chem. 2005, 44, 7661–7670.
(7) (a) Hoganson, C. W.; Babcock, G. T. Science 1992, 277, 1953–1956.
(b) Petrouleas, V.; Koulougliotis, D.; Ioannidis, N. Biochemistry 2005,
44, 6723–6728.
(8) C¸ elenligil-C¸ etin, R.; Paraskevopoulou, P.; Dinda, R.; Lalioti, N.;
Sanakis, Y.; Rawashdeh, A. M.; Staples, R. J.; Sinn, E.; Stavropoulos,
P. Eur. J. Inorg. Chem. 2008, 673–677.
(9) (a) C¸ elenligil-C¸ etin, R.; Paraskevopoulou, P.; Dinda, R.; Staples, R. J.;
Sinn, E.; Rath, N. P.; Stavropoulos, P. Inorg. Chem. 2008, 47, 1165–
1172. (b) Jones, M. B.; MacBeth, C. E. Inorg. Chem. 2007, 46, 8117–
8119.
Inorganic Chemistry, Vol. 47, No. 23, 2008 10999